KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Debt Ratio (2017 - 2026)

Aquestive Therapeutics has reported Debt Ratio over the past 9 years, most recently at 0.23 for Q4 2025.

  • For Q4 2025, Debt Ratio fell 27.08% year-over-year to 0.23; the TTM value through Dec 2025 reached 0.23, down 27.08%, while the annual FY2025 figure was 0.23, 27.08% down from the prior year.
  • Debt Ratio for Q4 2025 was 0.23 at Aquestive Therapeutics, up from 0.22 in the prior quarter.
  • Over five years, Debt Ratio peaked at 1.02 in Q3 2022 and troughed at 0.12 in Q1 2024.
  • A 5-year average of 0.56 and a median of 0.6 in 2021 define the central range for Debt Ratio.
  • Biggest five-year swings in Debt Ratio: tumbled 81.98% in 2024 and later soared 165.07% in 2025.
  • Year by year, Debt Ratio stood at 0.86 in 2021, then rose by 5.73% to 0.91 in 2022, then tumbled by 47.53% to 0.48 in 2023, then plummeted by 33.11% to 0.32 in 2024, then fell by 27.08% to 0.23 in 2025.
  • Business Quant data shows Debt Ratio for AQST at 0.23 in Q4 2025, 0.22 in Q3 2025, and 0.37 in Q2 2025.